The A-to-I mRNA-edited form of GABAA receptor alpha3 (Gabra3) was found in non-invasive breast cancers, and edited Gabra3 repressed the activation of the AKT pathway as well as cancer metastasis [160]. Here, GABRA3 is linked to cancer.